Cargando…
Group testing via hypergraph factorization applied to COVID-19
Large scale screening is a critical tool in the life sciences, but is often limited by reagents, samples, or cost. An important recent example is the challenge of achieving widespread COVID-19 testing in the face of substantial resource constraints. To tackle this challenge, screening methods must e...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983763/ https://www.ncbi.nlm.nih.gov/pubmed/35383149 http://dx.doi.org/10.1038/s41467-022-29389-z |
_version_ | 1784682029358514176 |
---|---|
author | Hong, David Dey, Rounak Lin, Xihong Cleary, Brian Dobriban, Edgar |
author_facet | Hong, David Dey, Rounak Lin, Xihong Cleary, Brian Dobriban, Edgar |
author_sort | Hong, David |
collection | PubMed |
description | Large scale screening is a critical tool in the life sciences, but is often limited by reagents, samples, or cost. An important recent example is the challenge of achieving widespread COVID-19 testing in the face of substantial resource constraints. To tackle this challenge, screening methods must efficiently use testing resources. However, given the global nature of the pandemic, they must also be simple (to aid implementation) and flexible (to be tailored for each setting). Here we propose HYPER, a group testing method based on hypergraph factorization. We provide theoretical characterizations under a general statistical model, and carefully evaluate HYPER with alternatives proposed for COVID-19 under realistic simulations of epidemic spread and viral kinetics. We find that HYPER matches or outperforms the alternatives across a broad range of testing-constrained environments, while also being simpler and more flexible. We provide an online tool to aid lab implementation: http://hyper.covid19-analysis.org. |
format | Online Article Text |
id | pubmed-8983763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-89837632022-04-22 Group testing via hypergraph factorization applied to COVID-19 Hong, David Dey, Rounak Lin, Xihong Cleary, Brian Dobriban, Edgar Nat Commun Article Large scale screening is a critical tool in the life sciences, but is often limited by reagents, samples, or cost. An important recent example is the challenge of achieving widespread COVID-19 testing in the face of substantial resource constraints. To tackle this challenge, screening methods must efficiently use testing resources. However, given the global nature of the pandemic, they must also be simple (to aid implementation) and flexible (to be tailored for each setting). Here we propose HYPER, a group testing method based on hypergraph factorization. We provide theoretical characterizations under a general statistical model, and carefully evaluate HYPER with alternatives proposed for COVID-19 under realistic simulations of epidemic spread and viral kinetics. We find that HYPER matches or outperforms the alternatives across a broad range of testing-constrained environments, while also being simpler and more flexible. We provide an online tool to aid lab implementation: http://hyper.covid19-analysis.org. Nature Publishing Group UK 2022-04-05 /pmc/articles/PMC8983763/ /pubmed/35383149 http://dx.doi.org/10.1038/s41467-022-29389-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Hong, David Dey, Rounak Lin, Xihong Cleary, Brian Dobriban, Edgar Group testing via hypergraph factorization applied to COVID-19 |
title | Group testing via hypergraph factorization applied to COVID-19 |
title_full | Group testing via hypergraph factorization applied to COVID-19 |
title_fullStr | Group testing via hypergraph factorization applied to COVID-19 |
title_full_unstemmed | Group testing via hypergraph factorization applied to COVID-19 |
title_short | Group testing via hypergraph factorization applied to COVID-19 |
title_sort | group testing via hypergraph factorization applied to covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983763/ https://www.ncbi.nlm.nih.gov/pubmed/35383149 http://dx.doi.org/10.1038/s41467-022-29389-z |
work_keys_str_mv | AT hongdavid grouptestingviahypergraphfactorizationappliedtocovid19 AT deyrounak grouptestingviahypergraphfactorizationappliedtocovid19 AT linxihong grouptestingviahypergraphfactorizationappliedtocovid19 AT clearybrian grouptestingviahypergraphfactorizationappliedtocovid19 AT dobribanedgar grouptestingviahypergraphfactorizationappliedtocovid19 |